Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.950
-0.320 (-7.49%)
At close: Apr 28, 2026, 4:00 PM EDT
3.930
-0.020 (-0.51%)
After-hours: Apr 28, 2026, 7:40 PM EDT
Perspective Therapeutics Employees
As of December 31, 2025, Perspective Therapeutics had 166 total employees, including 163 full-time and 3 part-time employees. The number of employees increased by 26 or 18.57% compared to the previous year.
Employees
166
Change (1Y)
26
Growth (1Y)
18.57%
Revenue / Employee
$5,325
Profits / Employee
-$621,211
Market Cap
450.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,400 |
| Orthofix Medical | 1,605 |
| Tactile Systems Technology | 1,086 |
| Cytek Biosciences | 702 |
| OrthoPediatrics | 602 |
| Pacific Biosciences of California | 485 |
| Beta Bionics | 423 |
| SI-BONE | 376 |
CATX News
- 4 days ago - Perspective Therapeutics to Provide Several Upcoming Corporate Updates - GlobeNewsWire
- 8 days ago - Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting - GlobeNewsWire
- 26 days ago - Perspective Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 - GlobeNewsWire
- 6 weeks ago - Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 3 months ago - Perspective Therapeutics Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts